How Sanofi stacks up

SNY · against 588 other Healthcare companies listed in US-listed

Valuation

88/ 100

Near the top of its peers.

Ranked #32 of 589 · scores higher than 95% of peers

Bars: peers in each 10-point band of the valuation score

27 peers with a valuation score of 80–89, including SNY · Click a bar to see the companies

Why valuation scores 88?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.

higher earnings for the price paid: stronger than 72% of peers. Earnings yield: 8.1% vs peer median 1.5%
more operating profit (EBITDA) for the company's total value: stronger than 85% of peers. EBITDA yield: 12.0% vs peer median 4.0%
more free cash flow for the price paid: stronger than 89% of peers. Free cash flow yield: 7.5% vs peer median 0.0%

Metric by metric

Position: dot = SNY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	SNY	Peer median	Better than	Weight
Earnings yieldHigher is better · 577 reported	4.1%	-4.3%	85%	30%
EBITDA yieldHigher is better · 578 reported	12.0%	-0.8%	90%	50%
Free cash flow yieldHigher is better · 553 reported	7.3%	-2.3%	90%	20%
Book yieldHigher is better · 587 reported	74.5%	25.9%	86%	Context only

Ranking by valuation score

Top 5 and the companies ranked around SNY

Rank	Company	Market cap	Valuation	Overall
1	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	98	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	96	97
2	CorMedix Inc.CRMD · US-listed	433M USD	96	81
2	Community Health Systems, Inc.CYH · US-listed	289M USD	96	57
2	InMode Ltd.INMD · US-listed	810M USD	96	69
⋯
29	AMN Healthcare Services, Inc.AMN · US-listed	1.8B USD	89	63
29	ANI Pharmaceuticals, Inc.ANIP · US-listed	1.7B USD	89	77
29	The Cigna GroupCI · US-listed	78.1B USD	89	60
32	Organigram Global Inc.OGI · US-listed	133M USD	88	51
32	SanofiSNY · US-listed	108.6B USD	88	66
34	GSK plcGSK · US-listed	97.5B USD	87	67
35	Amphastar Pharmaceuticals, Inc.AMPH · US-listed	1.2B USD	85	52
35	Indivior Pharmaceuticals, Inc.INDV · US-listed	4.3B USD	85	69
35	Organon & Co.OGN · US-listed	3.6B USD	85	43

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…